The impact of depression and somatic symptoms on treatment outcomes in patients with chronic prostatitis/chronic pelvic pain syndrome: A preliminary study in a naturalistic treatment setting

International Journal of Clinical Practice

Volumn 68, Issue 4, 2014, Pages 478-485

  Koh, J S ^a   Ko, H J ^b   Wang, S M ^c   Cho, K J ^a   Kim, J C ^a   Lee, S J ^c   Pae, C U ^c,d  

^a The Catholic University of Korea College of Medicine   (South Korea)

^b Seoul Metropolitan Eunpyeong Hospital   (South Korea)

^c The Catholic University of Korea   (South Korea)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; ASIAN; CHRONIC PAIN; CHRONIC PROSTATITIS; CLINICAL ASSESSMENT TOOL; CLINICAL PRACTICE; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; EUROQOL QUESTIONNAIRE 5 DIMENSIONS; HUMAN; KOREAN; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH CHRONIC PROSTATITIS SYMPTOM INDEX; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT HEALTH QUESTIONNAIRE 15; PATIENT HEALTH QUESTIONNAIRE 9; PELVIS PAIN SYNDROME; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SOMATIC SYMPTOM; SYMPTOM; TREATMENT RESPONSE; VISUAL ANALOG SCALE; COMPLICATION; MIDDLE AGED; PROSTATITIS; PSYCHOLOGY; SOMATOSENSORY DISORDER; TREATMENT OUTCOME;

DEPRESSION; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATITIS; SOMATOSENSORY DISORDERS; TREATMENT OUTCOME;

EID: 84897445609     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/ijcp.12340     Document Type: Article

References (48)

1. Nickel JC,. Understanding chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). World J Urol 2013; 31: 709-10.
2. Mahal BA, Cohen JM, Allsop SA, et al. The role of phenotyping in chronic prostatitis/chronic pelvic pain syndrome. Current Urol Rep 2011; 12: 297-303.
3. Krieger JN, Nyberg L Jr, Nickel JC,. NIH consensus definition and classification of prostatitis. JAMA 1999; 282: 236-7.
4. Roberts RO, Lieber MM, Rhodes T, et al. Prevalence of a physician-assigned diagnosis of prostatitis: the Olmsted County study of urinary symptoms and health status among men. Urology 1998; 51: 578-84.
5. Liang CZ, Li HJ, Wang ZP, et al. The prevalence of prostatitis-like symptoms in China. J Urol 2009; 182: 558-63.
6. Ejike CE, Ezeanyika LU,. Prevalence of chronic prostatitis symptoms in a randomly surveyed adult population of urban-community-dwelling Nigerian males. Int J Urol 2008; 15: 340-3.
7. Clemens JQ, Meenan RT, O'Keeffe Rosetti MC, et al. Prevalence of and risk factors for prostatitis: population based assessment using physician assigned diagnoses. J Urol 2007; 178: 1333-7.
8. Turner JA, Ciol MA, Von Korff M, Berger R,. Prognosis of patients with new prostatitis/pelvic pain syndrome episodes. J Urol 2004; 172: 538-41.
9. Nickel JC,. The biolomedical model has failed ! So what's next? Contemp Urol 2006; 1: 31-9.
10. Nickel JC, Shoskes DA, Wagenlehner FM,. Management of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): the studies, the evidence, and the impact. World J Urol 2013; 31: 747-53.
11. Pontari MA, Ruggieri MR,. Mechanisms in prostatitis/chronic pelvic pain syndrome. J Urol 2008; 179: S61-7.
12. Schaeffer AJ, Knauss JS, Landis JR, et al. Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis: the National Institutes of Health Chronic Prostatitis Cohort Study. J Urol 2002; 168: 1048-53.
13. Nickel JC, Alexander RB, Schaeffer AJ, et al. Leukocytes and bacteria in men with chronic prostatitis/chronic pelvic pain syndrome compared to asymptomatic controls. J Urol 2003; 170: 818-22.
14. Nickel JC,. The three As of chronic prostatitis therapy: antibiotics, alpha-blockers and anti-inflammatories. What is the evidence? BJU Int 2004; 94: 1230-3.
15. Nickel JC, Roehrborn CG, O'Leary MP, et al. Examination of the relationship between symptoms of prostatitis and histological inflammation: baseline data from the REDUCE chemoprevention trial. J Urol 2007; 178: 896-900; discussion 1.
16. Clemens JQ, Brown SO, Calhoun EA,. Mental health diagnoses in patients with interstitial cystitis/painful bladder syndrome and chronic prostatitis/chronic pelvic pain syndrome: a case/control study. J Urol 2008; 180: 1378-82.
17. Chung SD, Huang CC, Lin HC,. Chronic prostatitis and depressive disorder: a three year population-based study. J Affect Disord 2011; 134: 404-9.
18. Tripp DA, Curtis Nickel J, Landis JR, et al. Predictors of quality of life and pain in chronic prostatitis/chronic pelvic pain syndrome: findings from the National Institutes of Health Chronic Prostatitis Cohort Study. BJU Int 2004; 94: 1279-82.
19. Kalibatseva Z, Leong FT,. Depression among Asian Americans: review and recommendations. Depress Res Treat 2011; 2011: 320902.
20. Lee P, Zhang M, Hong JP, et al. Frequency of painful physical symptoms with major depressive disorder in asia: relationship with disease severity and quality of life. J Clin Psychiatry 2009; 70: 83-91.
21. Xia SJ, Cui D, Jiang Q,. An overview of prostate diseases and their characteristics specific to Asian men. Asian J Androl 2012; 14: 458-64.
22. Lee SW, Cheah PY, Liong ML, et al. Demographic and clinical characteristics of chronic prostatitis: prospective comparison of the University of Sciences Malaysia Cohort with the United States National Institutes of Health Cohort. J Urol 2007; 177: 153-7; discussion 8.
23. Chong CH, Ryu DS, Oh TH,. The Korean Version of NIH-Chronic Prostatitis Symptom Index (NIH- CPSI): validation study and characteristics on chronic prostatitis. Korean J Urol 2001; 42: 511-20.
24. Han C, Jo SA, Kwak JH, et al. Validation of the Patient Health Questionnaire-9 Korean version in the elderly population: the Ansan Geriatric study. Compr Psychiatry 2008; 49: 218-23.
25. Kroenke K, Spitzer RL, Williams JB,. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001; 16: 606-13.
26. Han C, Pae CU, Patkar AA, et al. Psychometric properties of the Patient Health Questionnaire-15 (PHQ-15) for measuring the somatic symptoms of psychiatric outpatients. Psychosomatics 2009; 50: 580-5.
27. Kroenke K, Spitzer RL, Williams JB,. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 2002; 64: 258-66.
28. Kim MH, Cho YS, Uhm WS, et al. Cross-cultural adaptation and validation of the Korean version of the EQ-5D in patients with rheumatic diseases. Qual Life Res 2005; 14: 1401-6.
29. EuroQol group. EQ-5D. www.euroqol.org (accessed July 10 2013).
30. Litwin MS,. A review of the development and validation of the National Institutes of Health Chronic Prostatitis Symptom Index. Urology 2002; 60: 14-8; discussion 8-9.
31. Litwin MS, McNaughton-Collins M, Fowler FJ Jr, et al. The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol 1999; 162: 369-75.
32. Propert KJ, Litwin MS, Wang Y, et al. Responsiveness of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI). Qual Life Res 2006; 15: 299-305.
33. Lowe B, Unutzer J, Callahan CM, et al. Monitoring depression treatment outcomes with the patient health questionnaire-9. Med Care 2004; 42: 1194-201.
34. Han C, Pae CU, Lee BH, et al. Venlafaxine versus mirtazapine in the treatment of undifferentiated somatoform disorder: a 12-week prospective, open-label, randomized, parallel-group trial. Clin Drug Invest 2008; 28: 251-61.
35. Shim YS, Pae CU, Kim SW, et al. Effects of repeated dosing with Udenafil (Zydena) on cognition, somatization and erection in patients with erectile dysfunction: a pilot study. Int J Impot Res 2011; 23: 109-14.
36. Moore M, Ali S, Stuart B, et al. Depression management in primary care: an observational study of management changes related to PHQ-9 score for depression monitoring. Br J Gen Pract 2012; 62: e451-7.
37. Interian A, Allen LA, Gara MA, et al. Somatic complaints in primary care: further examining the validity of the Patient Health Questionnaire (PHQ-15). Psychosomatics 2006; 47: 392-8.
38. Lee MS, Yum SY, Hong JP, et al. Association between painful physical symptoms and clinical outcomes in Korean patients with major depressive disorder: a three-month observational study. Psychiatry Invest 2009; 6: 255-63.
39. Zhao FL, Yue M, Yang H, et al. Health-related quality of life in Chinese patients with chronic prostatitis/chronic pelvic pain syndrome. Qual Life Res 2010; 19: 1273-83.
40. Ahn SG, Kim SH, Chung KI, et al. Depression, anxiety, stress perception, and coping strategies in Korean military patients with chronic prostatitis/chronic pelvic pain syndrome. Korean J Urol 2012; 53: 643-8.
41. Zhang GX, Bai WJ, Xu T, Wang XF,. A preliminary evaluation of the psychometric profiles in Chinese men with chronic prostatitis/chronic pelvic pain syndrome. Chin Med J 2011; 124: 514-8.
42. Jang TL, Schaeffer AJ,. The role of cytokines in prostatitis. World J Urol 2003; 21: 95-9.
43. Watanabe T, Inoue M, Sasaki K, et al. Nerve growth factor level in the prostatic fluid of patients with chronic prostatitis/chronic pelvic pain syndrome is correlated with symptom severity and response to treatment. BJU Int 2011; 108: 248-51.
44. Kullisaar T, Turk S, Punab M, Mandar R,. Oxidative stress-cause or consequence of male genital tract disorders? Prostate 2012; 72: 977-83.
45. Dimitrakov J, Joffe HV, Soldin SJ, et al. Adrenocortical hormone abnormalities in men with chronic prostatitis/chronic pelvic pain syndrome. Urology 2008; 71: 261-6.
46. Xia D, Wang P, Chen J, et al. Fluoxetine ameliorates symptoms of refractory chronic prostatitis/chronic pelvic pain syndrome. Chin Med J 2011; 124: 2158-61.
47. Nickel JC, Mullins C, Tripp DA,. Development of an evidence-based cognitive behavioral treatment program for men with chronic prostatitis/chronic pelvic pain syndrome. World J Urol 2008; 26: 167-72.
48. Krannich M, Rief W, Martin A, et al. How do somatoform and depressive symptoms and syndromes affect life satisfaction? Results from a representative population survey in Germany. Psychother Psychosom Med Psychol 2013; 63: 217-24.